Live from the NIH registry
Studies recruiting near Santa Ana right now
Top 25 of 1,979 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Lundquist Biomedical Research Institute at Harbor UCLA Medical Center — Torrance, California (27.2 mi)
· Sponsor: University of Michigan
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Multiple conditions
N/A
Observational 4,000 participants sought
Congenital Muscle Disease International Registry (www.cmdir.org) — Lakewood, California (16.6 mi)
· Sponsor: Cure CMD
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
City of Hope (Adults and Pediatrics) — Duarte, California (28.4 mi)
· Sponsor: Pierre Fabre Medicament
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
Children's Hospital Orange County — Orange, California (3.9 mi)
· Sponsor: New York Medical College
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (3.9 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Orange County — Orange, California (3.9 mi)
· Sponsor: National Cancer Institute (NCI)
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
N/A
Interventional 808 participants sought
VA Long Beach Healthcare System, Long Beach, CA — Long Beach, California (17.8 mi)
· Sponsor: VA Office of Research and Development
Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke
Chronic Stroke Patients
N/A
Interventional 32 participants sought
University of California Irvine — Irvine, California (5.7 mi)
· Sponsor: University of California, Irvine
Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 50 participants sought
City of Hope at Irvine Lennar — Irvine, California (5.7 mi)
· Sponsor: City of Hope Medical Center
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Sepsis, Acute Kidney Injury
Phase 2
Interventional 124 participants sought
Research Site — Newport Beach, California (8.6 mi)
· Sponsor: AstraZeneca
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
Marvel Clinical Research — Huntington Beach, California (8.6 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067 — Irvine, California (5.7 mi)
· Sponsor: AbbVie
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina Associates of Southern California — Huntington Beach, California (8.6 mi)
· Sponsor: Boehringer Ingelheim
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 78 participants sought
City of Hope Medical Center — Duarte, California (28.4 mi)
· Sponsor: City of Hope Medical Center
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of California - Irvine — Irvine, California (5.7 mi)
· Sponsor: AskBio Inc
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
Alzheimer Disease
Phase 1
Interventional 18 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (8.6 mi)
· Sponsor: Regeneration Biomedical, Inc.
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (3.9 mi)
· Sponsor: University of California, Irvine
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 226 participants sought
Research Site — Irvine, California (5.7 mi)
· Sponsor: AstraZeneca
MiGo Tracker Remote Monitoring of Home Exercise After Stroke
Subacute Stroke
N/A
Interventional 50 participants sought
Rancho Research Institute, Inc — Downey, California (20.1 mi)
· Sponsor: Flint Rehabilitation Devices, LLC
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
City of Hope - Lennar Foundation Cancer Center — Irvine, California (5.7 mi)
· Sponsor: Hoffmann-La Roche
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Univ Cali Irvine ALS Neuromuscular — Orange, California (3.9 mi)
· Sponsor: Novartis Pharmaceuticals
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Irvine, California (5.7 mi)
· Sponsor: AstraZeneca
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of California, Irvine — Orange, California (3.9 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (4.5 mi)
· Sponsor: Takeda
Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
Follicular Helper T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified
Phase 2
Interventional 25 participants sought
City of Hope Medical Center — Duarte, California (28.4 mi)
· Sponsor: City of Hope Medical Center